XML

Understanding structured content: definition and benefits

In today’s digital age, the way we manage and utilize information has evolved dramatically. Conventionally, document content is unstructured, with text, figures, and tables that authors can freely arrange in the way they want to. By structuring content, we can shift from a document-based to a content and data-based approach. But what exactly is structured […]

Understanding structured content: definition and benefits Read More »

Fonto Why & How: How do I make an operation that opens a modal enabled in the correct situation?!

In this weekly series, Martin describes a question that was raised by a Fonto developer, how it was resolved and why Fonto behaved like that in the first place. This week, a developer reached out! They have a modal that manages a prolog: it can either insert a new prolog, or it can edit one.

Fonto Why & How: How do I make an operation that opens a modal enabled in the correct situation?! Read More »

Fonto Why & How: How to chunk a single XML file like NISO-STS or JATS

In this weekly series, Martin describes a question raised by a Fonto developer, how it was resolved and why Fonto behaved like that in the first place. This week is a follow-up to an earlier blog post on dealing with large documents! How did we chunk megabytes of XML?! This post is a follow-up to

Fonto Why & How: How to chunk a single XML file like NISO-STS or JATS Read More »

The Future of Standards: the ISO Annual Meeting 2022

We are present at ISO’s Annual Meeting, a meeting for all standards developing bodies worldwide. For the first time this year, the event is open to other organizations and companies that work with standards developing bodies. Against the spectacular backdrop of downtown Abu Dhabi, four full days of meetings, discussions and networking events are taking

The Future of Standards: the ISO Annual Meeting 2022 Read More »

Structured content for pharma

It takes pharma companies about five times longer to create content, compared to other industries. Delayed drug approvals turn into an average loss of $1 million dollars per day for pharma companies. Val Swisher and Regina Lynn Preciado from Content Rules recently published an interesting e-book: “Structured Content for Pharma – Making the Case for

Structured content for pharma Read More »

Scroll to Top